| 1 | Post Covid-19 symptoms among Covid-19 patients with comorbidities and non-comorbidities in Peninsular Malaysia | 1421 |
| 2 | Edible bird nest as a potential cognitive enhancer | 1288 |
| 3 | C-Abl inhibition; a novel therapeutic target for Parkinson’s disease | 1250 |
| 4 | Neuroprotective effect of edible bird’s nest in chronic cerebral hypoperfusion induced neurodegeneration in rats | 1229 |
| 5 | The promise of the Zebrafish model for Parkinson’s disease: today’s science and tomorrow’s treatment | 1165 |
| 6 | Tau protein as a biomarker for asphyxia: a possible forensic tool? | 1142 |
| 7 | Is sugar or fat worse? | 1132 |
| 8 | Depression following major life transitions in women: a review and theory | 1095 |
| 9 | Mechanisms of disordered neurodegenerative function: concepts and facts about the different roles of the protein kinase RNA-like endoplasmic reticulum kinase (PERK) | 1088 |
| 10 | Burnout in academia the physiological effects of contagion and isolation go beyond fear of contracting the Covid-19 virus | 1083 |
| 11 | Dual mTORC1/mTORC2 blocker as a possible therapy for tauopathy in cellular model | 1050 |
| 12 | Tubulin and tau: Possible targets for diagnosis of Parkinson’s and Alzheimer’s diseases | 1037 |
| 13 | Pharmacotherapy of alzheimer’s disease: seeking clarity in a time of uncertainty | 1035 |
| 14 | Integrated neural technologies: solutions beyond tomorrow | 1035 |
| 15 | Thyroxine (T4) transfer from blood to cerebrospinal fluid in sheep isolated perfused choroid plexus: role of
multidrug resistance-associated Proteins and Organic anion
Transporting Polypeptides | 1031 |
| 16 | Effect of intranasal stem cell administration on the nigrostriatal system in a mouse model of Parkinson's disease | 1029 |
| 17 | siRNA blocking of mammalian target of rapamycin (mTOR) attenuates pathology in annonacin-induced tauopathy in mice | 1011 |
| 18 | Genetic underpinnings in Alzheimer’s disease –
A review | 1002 |
| 19 | Interactions between cannabis and schizophrenia
in humans and rodents | 999 |
| 20 | Light-Emitting Diode (LED) therapy attenuates neurotoxicity of methanol-induced memory impairment and apoptosis in the hippocampus | 991 |
| 21 | Hormones in experimental autoimmune encephalomyelitis (EAE) animal models | 985 |
| 22 | Elevated serum α-synuclein autoantibodies in patients with Parkinson’s disease relative to Alzheimer’s disease and controls | 976 |
| 23 | Oxidative stress status and neuroprotection of tocotrienols in chronic cerebral hypoperfusion-induced neurodegeneration rat animal model | 966 |
| 24 | Editorial: biomarkers in neurology | 945 |
| 25 | Elevation of pro‑inflammatory and anti‑inflammatory cytokines in rat serum after acute methamphetamine treatment and traumatic brain injury | 927 |
| 26 | FOXRED1 silencing in mice: a possible animal model for leigh syndrome. | 919 |
| 27 | Atypical antipsychotic lumateperone effects on the adrenal gland with possible beneficial effect of quercetin co-administration | 915 |
| 28 | Editorial: contribution of translational animal models to the systems biology of neurodegenerative disorders | 906 |
| 29 | Neurotoxin‑induced rodent models of Parkinson’s disease: benefits and drawbacks | 890 |
| 30 | Animal model for leigh syndrome | 879 |